| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 52 | 2022 | 447 | 11.040 |
Why?
|
| Inflammation | 44 | 2022 | 1030 | 5.770 |
Why?
|
| Dronabinol | 24 | 2021 | 84 | 5.300 |
Why?
|
| T-Lymphocytes | 64 | 2021 | 597 | 5.150 |
Why?
|
| Gastrointestinal Microbiome | 19 | 2022 | 122 | 5.150 |
Why?
|
| Polychlorinated Dibenzodioxins | 28 | 2022 | 38 | 4.790 |
Why?
|
| Mice | 215 | 2022 | 8474 | 4.750 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 17 | 2020 | 133 | 4.750 |
Why?
|
| Enterotoxins | 20 | 2021 | 40 | 4.670 |
Why?
|
| Cytokines | 54 | 2022 | 866 | 4.630 |
Why?
|
| Mice, Inbred C57BL | 139 | 2022 | 2791 | 4.420 |
Why?
|
| Gene Expression Regulation | 35 | 2022 | 1293 | 4.390 |
Why?
|
| Leukocytes, Mononuclear | 15 | 2022 | 124 | 4.220 |
Why?
|
| Animals | 256 | 2022 | 20881 | 4.100 |
Why?
|
| Receptors, Aryl Hydrocarbon | 21 | 2022 | 46 | 4.030 |
Why?
|
| Apoptosis | 63 | 2021 | 1641 | 3.900 |
Why?
|
| Hyaluronan Receptors | 20 | 2017 | 142 | 3.780 |
Why?
|
| Multiple Sclerosis | 13 | 2019 | 132 | 3.670 |
Why?
|
| Th17 Cells | 15 | 2022 | 116 | 3.510 |
Why?
|
| Lymphocyte Activation | 50 | 2022 | 397 | 3.510 |
Why?
|
| T-Lymphocytes, Regulatory | 28 | 2021 | 199 | 3.440 |
Why?
|
| Myeloid Cells | 10 | 2017 | 57 | 3.120 |
Why?
|
| Th1 Cells | 9 | 2019 | 101 | 2.970 |
Why?
|
| Colitis | 26 | 2021 | 156 | 2.940 |
Why?
|
| Epigenesis, Genetic | 12 | 2022 | 163 | 2.870 |
Why?
|
| Endocannabinoids | 8 | 2021 | 32 | 2.820 |
Why?
|
| Histones | 5 | 2022 | 111 | 2.670 |
Why?
|
| Cannabidiol | 9 | 2021 | 31 | 2.640 |
Why?
|
| Hypersensitivity, Delayed | 10 | 2021 | 19 | 2.620 |
Why?
|
| Stilbenes | 13 | 2016 | 57 | 2.600 |
Why?
|
| Anti-Inflammatory Agents | 15 | 2021 | 234 | 2.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2022 | 1506 | 2.500 |
Why?
|
| Cell Differentiation | 29 | 2022 | 1034 | 2.370 |
Why?
|
| Macrophages | 31 | 2022 | 647 | 2.300 |
Why?
|
| Receptor, Cannabinoid, CB1 | 12 | 2019 | 68 | 2.230 |
Why?
|
| RNA, Long Noncoding | 4 | 2022 | 54 | 2.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 14 | 2019 | 226 | 2.100 |
Why?
|
| Indoles | 13 | 2020 | 146 | 2.080 |
Why?
|
| Interleukin-2 | 24 | 2012 | 133 | 2.010 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 14 | 2021 | 87 | 2.000 |
Why?
|
| Acute Lung Injury | 6 | 2018 | 35 | 2.000 |
Why?
|
| Female | 153 | 2022 | 38074 | 1.930 |
Why?
|
| Arachidonic Acids | 6 | 2021 | 97 | 1.920 |
Why?
|
| Dendritic Cells | 12 | 2022 | 201 | 1.870 |
Why?
|
| Hepatitis, Autoimmune | 5 | 2022 | 22 | 1.830 |
Why?
|
| Polyunsaturated Alkamides | 5 | 2021 | 17 | 1.820 |
Why?
|
| Cannabinoids | 11 | 2021 | 90 | 1.790 |
Why?
|
| DNA Methylation | 8 | 2022 | 193 | 1.790 |
Why?
|
| Disease Models, Animal | 46 | 2022 | 2550 | 1.770 |
Why?
|
| Immune Tolerance | 11 | 2020 | 114 | 1.770 |
Why?
|
| Thymus Gland | 28 | 2015 | 97 | 1.700 |
Why?
|
| Diethylstilbestrol | 5 | 2018 | 45 | 1.700 |
Why?
|
| Signal Transduction | 42 | 2022 | 2689 | 1.680 |
Why?
|
| Ligands | 16 | 2022 | 317 | 1.600 |
Why?
|
| Lung | 15 | 2022 | 849 | 1.580 |
Why?
|
| Interleukin-10 | 8 | 2020 | 144 | 1.580 |
Why?
|
| Mice, Knockout | 43 | 2021 | 1692 | 1.460 |
Why?
|
| Metabolome | 2 | 2021 | 15 | 1.420 |
Why?
|
| Gene Expression Profiling | 10 | 2018 | 498 | 1.370 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2015 | 154 | 1.350 |
Why?
|
| Obesity | 9 | 2022 | 1076 | 1.330 |
Why?
|
| T-Lymphocyte Subsets | 14 | 2019 | 126 | 1.320 |
Why?
|
| fas Receptor | 12 | 2015 | 54 | 1.300 |
Why?
|
| Interferon-gamma | 12 | 2019 | 241 | 1.230 |
Why?
|
| Carcinogenesis | 5 | 2018 | 124 | 1.210 |
Why?
|
| Dysbiosis | 9 | 2022 | 24 | 1.170 |
Why?
|
| Panax | 11 | 2020 | 31 | 1.140 |
Why?
|
| NF-kappa B | 16 | 2020 | 432 | 1.110 |
Why?
|
| Toll-Like Receptor 4 | 8 | 2020 | 114 | 1.070 |
Why?
|
| Spleen | 25 | 2021 | 301 | 1.050 |
Why?
|
| Plant Extracts | 13 | 2021 | 122 | 1.030 |
Why?
|
| Liver | 24 | 2021 | 1118 | 1.030 |
Why?
|
| Autoimmunity | 4 | 2018 | 118 | 1.010 |
Why?
|
| B-Lymphocytes | 15 | 2016 | 329 | 1.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 6 | 2021 | 58 | 1.010 |
Why?
|
| Colonic Neoplasms | 11 | 2022 | 299 | 1.000 |
Why?
|
| Cecum | 2 | 2021 | 39 | 0.990 |
Why?
|
| Humans | 97 | 2022 | 68618 | 0.980 |
Why?
|
| Phenotype | 17 | 2022 | 947 | 0.970 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2021 | 627 | 0.970 |
Why?
|
| Colon | 15 | 2021 | 168 | 0.970 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2019 | 240 | 0.970 |
Why?
|
| Immune System | 5 | 2021 | 63 | 0.960 |
Why?
|
| Adipose Tissue | 5 | 2019 | 221 | 0.960 |
Why?
|
| Microcystins | 6 | 2021 | 7 | 0.950 |
Why?
|
| Toxicity Tests | 2 | 2018 | 26 | 0.950 |
Why?
|
| Inflammation Mediators | 13 | 2021 | 244 | 0.950 |
Why?
|
| Melanoma, Experimental | 3 | 2021 | 95 | 0.950 |
Why?
|
| Chemokines | 9 | 2019 | 119 | 0.950 |
Why?
|
| Fas Ligand Protein | 12 | 2015 | 64 | 0.940 |
Why?
|
| Cell Proliferation | 18 | 2018 | 1174 | 0.900 |
Why?
|
| Lung Injury | 2 | 2015 | 38 | 0.900 |
Why?
|
| Thymocytes | 4 | 2018 | 11 | 0.900 |
Why?
|
| Transforming Growth Factor beta | 6 | 2019 | 384 | 0.880 |
Why?
|
| Autophagy | 5 | 2020 | 208 | 0.880 |
Why?
|
| Promoter Regions, Genetic | 9 | 2022 | 615 | 0.860 |
Why?
|
| Anti-Bacterial Agents | 10 | 2021 | 1026 | 0.850 |
Why?
|
| Computational Biology | 3 | 2019 | 190 | 0.850 |
Why?
|
| Receptor, Cannabinoid, CB2 | 12 | 2021 | 27 | 0.840 |
Why?
|
| Intestinal Mucosa | 11 | 2022 | 219 | 0.830 |
Why?
|
| Myeloid-Derived Suppressor Cells | 5 | 2020 | 21 | 0.820 |
Why?
|
| Melanoma | 4 | 2019 | 335 | 0.820 |
Why?
|
| Endothelial Cells | 5 | 2020 | 384 | 0.820 |
Why?
|
| Cells, Cultured | 29 | 2021 | 2673 | 0.810 |
Why?
|
| Cannabinoid Receptor Agonists | 3 | 2021 | 20 | 0.800 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 247 | 0.800 |
Why?
|
| Th2 Cells | 4 | 2011 | 48 | 0.800 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 63 | 0.800 |
Why?
|
| Diet, High-Fat | 9 | 2022 | 81 | 0.770 |
Why?
|
| Gene Expression | 9 | 2022 | 770 | 0.770 |
Why?
|
| Disease Progression | 6 | 2019 | 1038 | 0.770 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 170 | 0.770 |
Why?
|
| Gene Regulatory Networks | 3 | 2016 | 94 | 0.770 |
Why?
|
| Down-Regulation | 13 | 2019 | 447 | 0.770 |
Why?
|
| Mast Cells | 4 | 2021 | 113 | 0.760 |
Why?
|
| Graft Rejection | 4 | 2018 | 458 | 0.760 |
Why?
|
| Dextran Sulfate | 16 | 2022 | 88 | 0.760 |
Why?
|
| Sepsis | 2 | 2014 | 233 | 0.760 |
Why?
|
| Polymers | 9 | 2020 | 244 | 0.760 |
Why?
|
| Pneumonia | 3 | 2021 | 110 | 0.750 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2021 | 31 | 0.750 |
Why?
|
| Carcinogens | 4 | 2018 | 86 | 0.750 |
Why?
|
| Immunologic Factors | 3 | 2021 | 87 | 0.730 |
Why?
|
| Transcriptome | 3 | 2022 | 164 | 0.730 |
Why?
|
| Adjuvants, Immunologic | 4 | 2010 | 63 | 0.730 |
Why?
|
| STAT3 Transcription Factor | 5 | 2018 | 86 | 0.720 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 57 | 0.710 |
Why?
|
| NADPH Oxidase 2 | 5 | 2020 | 16 | 0.710 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2022 | 59 | 0.710 |
Why?
|
| Bryostatins | 6 | 2012 | 32 | 0.710 |
Why?
|
| Cell Line | 22 | 2021 | 1752 | 0.710 |
Why?
|
| Cannabis | 3 | 2019 | 115 | 0.710 |
Why?
|
| Fetus | 5 | 2015 | 157 | 0.700 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 11 | 0.700 |
Why?
|
| Antineoplastic Agents | 8 | 2021 | 1070 | 0.690 |
Why?
|
| Interleukin-6 | 7 | 2015 | 330 | 0.690 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2022 | 231 | 0.690 |
Why?
|
| AC133 Antigen | 1 | 2019 | 5 | 0.670 |
Why?
|
| NADPH Oxidases | 5 | 2019 | 80 | 0.670 |
Why?
|
| Integrin alpha Chains | 1 | 2019 | 9 | 0.670 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 24 | 0.660 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.650 |
Why?
|
| Monocytes | 5 | 2022 | 210 | 0.650 |
Why?
|
| Neoplasms, Experimental | 9 | 2003 | 118 | 0.650 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 114 | 0.650 |
Why?
|
| Membrane Glycoproteins | 9 | 2014 | 370 | 0.650 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2018 | 15 | 0.640 |
Why?
|
| NF-E2-Related Factor 2 | 5 | 2020 | 110 | 0.640 |
Why?
|
| Beclin-1 | 1 | 2018 | 11 | 0.640 |
Why?
|
| Multigene Family | 3 | 2023 | 93 | 0.640 |
Why?
|
| Chemokine CCL2 | 4 | 2017 | 101 | 0.640 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 11 | 0.630 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 84 | 0.630 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 214 | 0.630 |
Why?
|
| Male | 55 | 2022 | 37321 | 0.620 |
Why?
|
| Thinness | 1 | 2018 | 14 | 0.620 |
Why?
|
| Leptin | 6 | 2018 | 80 | 0.620 |
Why?
|
| Mice, Inbred C3H | 10 | 2021 | 134 | 0.610 |
Why?
|
| Interleukin-4 | 14 | 2014 | 69 | 0.610 |
Why?
|
| Exons | 2 | 2011 | 122 | 0.610 |
Why?
|
| Lymph Nodes | 14 | 2021 | 258 | 0.610 |
Why?
|
| Brain | 8 | 2020 | 2176 | 0.610 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 10c | 1 | 2017 | 1 | 0.600 |
Why?
|
| RNA Interference | 6 | 2022 | 266 | 0.600 |
Why?
|
| Colonic Polyps | 2 | 2017 | 63 | 0.600 |
Why?
|
| Argonaute Proteins | 1 | 2017 | 13 | 0.590 |
Why?
|
| Blood-Brain Barrier | 4 | 2021 | 99 | 0.590 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 284 | 0.590 |
Why?
|
| Receptors, Cannabinoid | 11 | 2016 | 26 | 0.590 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.590 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 201 | 0.590 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 334 | 0.590 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.590 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 290 | 0.580 |
Why?
|
| Models, Molecular | 1 | 2019 | 546 | 0.570 |
Why?
|
| Environmental Pollutants | 9 | 2010 | 180 | 0.570 |
Why?
|
| Flow Cytometry | 22 | 2012 | 489 | 0.570 |
Why?
|
| Databases, Genetic | 1 | 2016 | 52 | 0.560 |
Why?
|
| Cytotoxicity, Immunologic | 12 | 2007 | 66 | 0.560 |
Why?
|
| Colitis, Ulcerative | 6 | 2020 | 53 | 0.560 |
Why?
|
| Interleukin-15 | 1 | 2016 | 66 | 0.550 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 163 | 0.540 |
Why?
|
| Autoimmune Diseases | 7 | 2021 | 186 | 0.540 |
Why?
|
| Concanavalin A | 5 | 2022 | 22 | 0.530 |
Why?
|
| Antioxidants | 5 | 2020 | 304 | 0.530 |
Why?
|
| Forkhead Transcription Factors | 8 | 2021 | 94 | 0.530 |
Why?
|
| TRPV Cation Channels | 2 | 2016 | 17 | 0.520 |
Why?
|
| Carbazoles | 4 | 2021 | 46 | 0.520 |
Why?
|
| Carrier Proteins | 3 | 2016 | 597 | 0.520 |
Why?
|
| Hyaluronic Acid | 4 | 2007 | 206 | 0.520 |
Why?
|
| Up-Regulation | 12 | 2020 | 682 | 0.520 |
Why?
|
| Graft vs Host Reaction | 1 | 2015 | 4 | 0.520 |
Why?
|
| Base Sequence | 11 | 2018 | 1015 | 0.520 |
Why?
|
| Interleukin-12 | 1 | 2015 | 75 | 0.510 |
Why?
|
| Capillary Permeability | 4 | 2015 | 69 | 0.510 |
Why?
|
| Calgranulin A | 1 | 2015 | 5 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 756 | 0.500 |
Why?
|
| Phytotherapy | 7 | 2020 | 53 | 0.500 |
Why?
|
| Skin Transplantation | 1 | 2015 | 45 | 0.500 |
Why?
|
| CD11b Antigen | 6 | 2015 | 47 | 0.490 |
Why?
|
| PPAR gamma | 1 | 2015 | 95 | 0.480 |
Why?
|
| Immunity, Cellular | 7 | 2021 | 80 | 0.480 |
Why?
|
| Ovalbumin | 4 | 2022 | 33 | 0.480 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2011 | 135 | 0.480 |
Why?
|
| Methylation | 3 | 2020 | 56 | 0.480 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 12 | 0.480 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 142 | 0.470 |
Why?
|
| Fecal Microbiota Transplantation | 5 | 2021 | 17 | 0.470 |
Why?
|
| Pregnancy | 10 | 2018 | 2334 | 0.470 |
Why?
|
| Breast Neoplasms | 4 | 2014 | 1536 | 0.470 |
Why?
|
| T-Lymphocytes, Cytotoxic | 10 | 1998 | 79 | 0.460 |
Why?
|
| Lymphoma | 6 | 2015 | 116 | 0.460 |
Why?
|
| Receptors, Chemokine | 5 | 2015 | 26 | 0.460 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 18 | 0.460 |
Why?
|
| Carmustine | 7 | 1991 | 14 | 0.460 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2011 | 91 | 0.460 |
Why?
|
| In Situ Nick-End Labeling | 10 | 2012 | 160 | 0.450 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 2022 | 77 | 0.450 |
Why?
|
| Veterans | 3 | 2017 | 904 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2017 | 235 | 0.440 |
Why?
|
| Maternal Exposure | 3 | 2012 | 75 | 0.440 |
Why?
|
| Cell Division | 13 | 2019 | 541 | 0.440 |
Why?
|
| Myocytes, Cardiac | 5 | 2020 | 442 | 0.430 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 45 | 0.430 |
Why?
|
| Interleukins | 5 | 2020 | 79 | 0.430 |
Why?
|
| Killer Cells, Natural | 5 | 2011 | 94 | 0.430 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 514 | 0.430 |
Why?
|
| Killer Cells, Lymphokine-Activated | 5 | 2012 | 11 | 0.430 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 157 | 0.430 |
Why?
|
| Oxidative Stress | 10 | 2021 | 718 | 0.420 |
Why?
|
| Capillary Leak Syndrome | 4 | 2016 | 4 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2018 | 320 | 0.420 |
Why?
|
| Venules | 1 | 2012 | 8 | 0.420 |
Why?
|
| Feces | 5 | 2020 | 88 | 0.410 |
Why?
|
| Binding Sites | 3 | 2019 | 631 | 0.410 |
Why?
|
| Protective Agents | 4 | 2021 | 36 | 0.410 |
Why?
|
| Arterioles | 1 | 2012 | 40 | 0.410 |
Why?
|
| Immunomodulation | 3 | 2019 | 35 | 0.410 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 232 | 0.410 |
Why?
|
| Middle Aged | 15 | 2022 | 21147 | 0.400 |
Why?
|
| Receptors, Interleukin-8B | 3 | 2020 | 9 | 0.400 |
Why?
|
| Lymphoma, T-Cell | 4 | 2013 | 19 | 0.400 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 99 | 0.400 |
Why?
|
| Erythrocytes | 3 | 2020 | 137 | 0.400 |
Why?
|
| Capillaries | 1 | 2012 | 105 | 0.400 |
Why?
|
| Case-Control Studies | 6 | 2020 | 1553 | 0.390 |
Why?
|
| Antigens, CD1d | 1 | 2011 | 2 | 0.390 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 7 | 0.390 |
Why?
|
| Immunologic Memory | 1 | 2011 | 75 | 0.390 |
Why?
|
| RNA, Messenger | 9 | 2020 | 1664 | 0.390 |
Why?
|
| Lung Neoplasms | 3 | 2012 | 1173 | 0.390 |
Why?
|
| Asthma | 3 | 2022 | 345 | 0.390 |
Why?
|
| Cell Separation | 8 | 2021 | 132 | 0.380 |
Why?
|
| Emodin | 2 | 2022 | 21 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 328 | 0.380 |
Why?
|
| Marine Toxins | 2 | 2021 | 14 | 0.380 |
Why?
|
| Bile Acids and Salts | 2 | 2022 | 19 | 0.380 |
Why?
|
| Brain Ischemia | 1 | 2017 | 665 | 0.380 |
Why?
|
| Interleukin-17 | 3 | 2019 | 62 | 0.370 |
Why?
|
| Firmicutes | 3 | 2023 | 4 | 0.370 |
Why?
|
| Insulin Resistance | 3 | 2022 | 241 | 0.370 |
Why?
|
| Molecular Sequence Data | 7 | 2012 | 1447 | 0.370 |
Why?
|
| Azoxymethane | 7 | 2022 | 28 | 0.370 |
Why?
|
| Disaccharides | 1 | 2010 | 9 | 0.360 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2021 | 88 | 0.360 |
Why?
|
| Transcriptional Activation | 4 | 2016 | 226 | 0.360 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2010 | 36 | 0.360 |
Why?
|
| Butyrates | 2 | 2021 | 14 | 0.360 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2020 | 117 | 0.360 |
Why?
|
| Biomarkers | 9 | 2022 | 1593 | 0.360 |
Why?
|
| Anticarcinogenic Agents | 3 | 2017 | 52 | 0.360 |
Why?
|
| Intestines | 3 | 2020 | 114 | 0.360 |
Why?
|
| Enzyme Inhibitors | 6 | 2020 | 659 | 0.350 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 85 | 0.350 |
Why?
|
| Mice, Inbred DBA | 15 | 2011 | 120 | 0.350 |
Why?
|
| Immunologic Tests | 1 | 2010 | 9 | 0.350 |
Why?
|
| Xenobiotics | 1 | 2010 | 17 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2015 | 626 | 0.350 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 34 | 0.350 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2019 | 109 | 0.340 |
Why?
|
| Glioma | 3 | 2015 | 140 | 0.340 |
Why?
|
| Lectins, C-Type | 2 | 2021 | 39 | 0.340 |
Why?
|
| Bone Marrow Cells | 5 | 2013 | 217 | 0.340 |
Why?
|
| Membrane Microdomains | 3 | 2015 | 32 | 0.340 |
Why?
|
| Cannabinoid Receptor Modulators | 4 | 2010 | 16 | 0.330 |
Why?
|
| Cell Line, Tumor | 12 | 2021 | 1851 | 0.330 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2018 | 114 | 0.330 |
Why?
|
| Biological Products | 3 | 2023 | 78 | 0.330 |
Why?
|
| Organ Transplantation | 1 | 2010 | 110 | 0.320 |
Why?
|
| Protein Binding | 5 | 2019 | 1027 | 0.320 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2019 | 25 | 0.310 |
Why?
|
| Antigen Presentation | 3 | 2011 | 76 | 0.310 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 25 | 0.310 |
Why?
|
| Macrophage Activation | 6 | 2018 | 75 | 0.310 |
Why?
|
| Macromolecular Substances | 2 | 2018 | 122 | 0.310 |
Why?
|
| Anti-Infective Agents | 2 | 2021 | 166 | 0.310 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 56 | 0.310 |
Why?
|
| Diynes | 2 | 2020 | 6 | 0.310 |
Why?
|
| Apigenin | 2 | 2020 | 10 | 0.310 |
Why?
|
| Amino Acids | 2 | 2019 | 131 | 0.310 |
Why?
|
| Macrolides | 2 | 2004 | 48 | 0.310 |
Why?
|
| Fatty Alcohols | 2 | 2020 | 14 | 0.310 |
Why?
|
| Sirtuin 1 | 4 | 2012 | 47 | 0.310 |
Why?
|
| Adult | 14 | 2022 | 21403 | 0.310 |
Why?
|
| Bacteria | 5 | 2022 | 193 | 0.300 |
Why?
|
| Inflammasomes | 4 | 2021 | 39 | 0.300 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 3 | 2020 | 17 | 0.300 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2006 | 140 | 0.300 |
Why?
|
| Persian Gulf Syndrome | 2 | 2018 | 27 | 0.300 |
Why?
|
| Fetal Blood | 2 | 2004 | 131 | 0.300 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 186 | 0.300 |
Why?
|
| Arginase | 3 | 2018 | 15 | 0.290 |
Why?
|
| Metal Nanoparticles | 2 | 2018 | 88 | 0.290 |
Why?
|
| DNA Fragmentation | 4 | 2018 | 85 | 0.290 |
Why?
|
| Metals | 2 | 2018 | 100 | 0.290 |
Why?
|
| Cannabinoid Receptor Antagonists | 4 | 2017 | 10 | 0.290 |
Why?
|
| Polyethylene Glycols | 3 | 2020 | 149 | 0.290 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 2 | 2018 | 34 | 0.290 |
Why?
|
| Cell Adhesion Molecules | 2 | 2021 | 199 | 0.290 |
Why?
|
| CD28 Antigens | 2 | 2020 | 12 | 0.280 |
Why?
|
| Endometriosis | 2 | 2018 | 56 | 0.280 |
Why?
|
| Caspases | 6 | 2018 | 194 | 0.280 |
Why?
|
| Membrane Potential, Mitochondrial | 3 | 2021 | 93 | 0.280 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 209 | 0.280 |
Why?
|
| Adoptive Transfer | 5 | 2018 | 100 | 0.280 |
Why?
|
| Phosphorylation | 5 | 2020 | 1200 | 0.270 |
Why?
|
| Lymphocytes | 6 | 2021 | 228 | 0.270 |
Why?
|
| HMGB1 Protein | 3 | 2021 | 23 | 0.270 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 561 | 0.270 |
Why?
|
| Superantigens | 3 | 2021 | 7 | 0.270 |
Why?
|
| Molecular Structure | 4 | 2021 | 397 | 0.270 |
Why?
|
| Lactones | 2 | 2015 | 64 | 0.270 |
Why?
|
| Enzyme Activation | 5 | 2015 | 791 | 0.270 |
Why?
|
| Peroxynitrous Acid | 5 | 2019 | 55 | 0.270 |
Why?
|
| Vascular Diseases | 1 | 2006 | 94 | 0.260 |
Why?
|
| Drug Discovery | 3 | 2021 | 94 | 0.260 |
Why?
|
| Calcium | 2 | 2004 | 929 | 0.260 |
Why?
|
| Gram-Negative Bacteria | 5 | 2021 | 55 | 0.260 |
Why?
|
| Water Pollutants, Chemical | 2 | 2020 | 328 | 0.260 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 144 | 0.260 |
Why?
|
| Leukemia | 1 | 2006 | 117 | 0.260 |
Why?
|
| Quercetin | 2 | 2016 | 16 | 0.260 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2021 | 137 | 0.260 |
Why?
|
| Skin | 2 | 2021 | 451 | 0.250 |
Why?
|
| Ionophores | 1 | 2004 | 25 | 0.250 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2021 | 226 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2019 | 1745 | 0.250 |
Why?
|
| Chromatin | 3 | 2020 | 76 | 0.250 |
Why?
|
| Genotype | 4 | 2021 | 786 | 0.240 |
Why?
|
| Liver Failure, Acute | 2 | 2015 | 49 | 0.240 |
Why?
|
| Aged | 8 | 2020 | 14862 | 0.240 |
Why?
|
| Streptomyces | 2 | 2021 | 15 | 0.240 |
Why?
|
| Acyltransferases | 2 | 2022 | 40 | 0.240 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2021 | 22 | 0.240 |
Why?
|
| Shock, Septic | 1 | 2005 | 101 | 0.240 |
Why?
|
| Intestine, Small | 2 | 2022 | 89 | 0.240 |
Why?
|
| Interleukin-13 | 2 | 2015 | 16 | 0.240 |
Why?
|
| Mice, Transgenic | 8 | 2020 | 1033 | 0.240 |
Why?
|
| Fibroblasts | 4 | 2020 | 902 | 0.240 |
Why?
|
| Hepatocytes | 4 | 2018 | 205 | 0.230 |
Why?
|
| Tumor Burden | 5 | 2022 | 132 | 0.230 |
Why?
|
| Stroke | 1 | 2017 | 2163 | 0.230 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2003 | 37 | 0.230 |
Why?
|
| Gram-Positive Bacteria | 4 | 2021 | 23 | 0.230 |
Why?
|
| Cluster Analysis | 2 | 2016 | 219 | 0.230 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 213 | 0.230 |
Why?
|
| Receptors, Drug | 2 | 2002 | 31 | 0.220 |
Why?
|
| Recombinant Proteins | 7 | 2021 | 742 | 0.220 |
Why?
|
| Chemokine CXCL10 | 2 | 2013 | 21 | 0.220 |
Why?
|
| Homeostasis | 2 | 2022 | 291 | 0.220 |
Why?
|
| Bacteriocins | 1 | 2023 | 4 | 0.220 |
Why?
|
| Injections, Intraperitoneal | 7 | 2019 | 89 | 0.220 |
Why?
|
| Transcription Factors | 3 | 2018 | 753 | 0.220 |
Why?
|
| Antigens, CD | 5 | 2019 | 230 | 0.220 |
Why?
|
| Piperidines | 4 | 2019 | 123 | 0.220 |
Why?
|
| Peptide Hydrolases | 2 | 2022 | 82 | 0.220 |
Why?
|
| Cell Cycle | 5 | 2019 | 312 | 0.220 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2015 | 74 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 786 | 0.210 |
Why?
|
| Leukemia, Lymphoid | 1 | 2002 | 17 | 0.210 |
Why?
|
| Molecular Conformation | 2 | 2021 | 128 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2E1 | 3 | 2016 | 11 | 0.210 |
Why?
|
| Cysteic Acid | 1 | 2022 | 2 | 0.210 |
Why?
|
| Escherichia coli | 2 | 2021 | 368 | 0.210 |
Why?
|
| Hexanes | 2 | 2012 | 7 | 0.210 |
Why?
|
| Pyrazoles | 4 | 2019 | 190 | 0.210 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2022 | 18 | 0.210 |
Why?
|
| Genome, Bacterial | 1 | 2022 | 20 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2015 | 507 | 0.200 |
Why?
|
| Wnt Proteins | 1 | 2022 | 57 | 0.200 |
Why?
|
| Cyclooxygenase 2 | 5 | 2016 | 160 | 0.200 |
Why?
|
| Molecular Docking Simulation | 2 | 2019 | 78 | 0.200 |
Why?
|
| Hepatic Stellate Cells | 3 | 2019 | 53 | 0.200 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2002 | 70 | 0.200 |
Why?
|
| Mice, Obese | 2 | 2019 | 33 | 0.200 |
Why?
|
| Discriminant Analysis | 1 | 2021 | 36 | 0.200 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2019 | 32 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2021 | 331 | 0.200 |
Why?
|
| Myocardium | 3 | 2020 | 1204 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type II | 6 | 2016 | 201 | 0.200 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 42 | 0.200 |
Why?
|
| Enzyme Induction | 2 | 2019 | 119 | 0.200 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2015 | 131 | 0.200 |
Why?
|
| Enterocytes | 1 | 2021 | 7 | 0.200 |
Why?
|
| Time Factors | 9 | 2018 | 4655 | 0.200 |
Why?
|
| Cell Survival | 6 | 2021 | 901 | 0.200 |
Why?
|
| Hepatitis, Animal | 1 | 2001 | 2 | 0.200 |
Why?
|
| Eczema | 1 | 2021 | 10 | 0.190 |
Why?
|
| Dietary Fats | 2 | 2019 | 103 | 0.190 |
Why?
|
| Hepatitis | 2 | 2015 | 25 | 0.190 |
Why?
|
| Calcimycin | 3 | 1992 | 32 | 0.190 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 8 | 1991 | 27 | 0.190 |
Why?
|
| Pseudomyxoma Peritonei | 1 | 2021 | 8 | 0.190 |
Why?
|
| Resorcinols | 1 | 2021 | 8 | 0.190 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 371 | 0.190 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 17 | 0.190 |
Why?
|
| Immunity, Innate | 4 | 2021 | 156 | 0.190 |
Why?
|
| Anthraquinones | 1 | 2021 | 18 | 0.190 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2019 | 82 | 0.190 |
Why?
|
| Metagenomics | 2 | 2019 | 11 | 0.190 |
Why?
|
| Lymphokines | 3 | 1990 | 49 | 0.190 |
Why?
|
| Fibrosis | 2 | 2020 | 371 | 0.190 |
Why?
|
| Endothelium, Vascular | 5 | 2017 | 371 | 0.190 |
Why?
|
| Silicon Dioxide | 2 | 2018 | 61 | 0.190 |
Why?
|
| Plants, Medicinal | 1 | 2021 | 43 | 0.190 |
Why?
|
| Microbiota | 1 | 2022 | 80 | 0.190 |
Why?
|
| Clostridiales | 1 | 2020 | 4 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2018 | 108 | 0.190 |
Why?
|
| Gulf War | 2 | 2017 | 22 | 0.190 |
Why?
|
| Demethylation | 1 | 2020 | 1 | 0.180 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2020 | 17 | 0.180 |
Why?
|
| Weight Loss | 4 | 2016 | 319 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2077 | 0.180 |
Why?
|
| Transcription Factor RelB | 1 | 2020 | 4 | 0.180 |
Why?
|
| Environmental Exposure | 2 | 2021 | 269 | 0.180 |
Why?
|
| CD8 Antigens | 6 | 1992 | 25 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 223 | 0.180 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2020 | 7 | 0.180 |
Why?
|
| Transplantation, Homologous | 3 | 2018 | 242 | 0.180 |
Why?
|
| Lipocalin-2 | 1 | 2020 | 19 | 0.180 |
Why?
|
| Neointima | 1 | 2020 | 7 | 0.180 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 434 | 0.180 |
Why?
|
| Kidney | 4 | 2021 | 945 | 0.180 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2020 | 317 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 248 | 0.180 |
Why?
|
| Doxorubicin | 2 | 2019 | 231 | 0.180 |
Why?
|
| Jugular Veins | 1 | 2020 | 37 | 0.180 |
Why?
|
| Alleles | 1 | 2021 | 386 | 0.180 |
Why?
|
| Serine Endopeptidases | 2 | 2017 | 50 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2015 | 710 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 411 | 0.170 |
Why?
|
| Lactic Acid | 1 | 2020 | 86 | 0.170 |
Why?
|
| Receptors, Interleukin-2 | 3 | 1997 | 42 | 0.170 |
Why?
|
| Follicular Atresia | 1 | 2019 | 1 | 0.170 |
Why?
|
| Ovarian Reserve | 1 | 2019 | 2 | 0.170 |
Why?
|
| Chronic Disease | 4 | 2019 | 1330 | 0.170 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 5 | 2015 | 41 | 0.170 |
Why?
|
| Mutation | 3 | 2021 | 1213 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2018 | 314 | 0.170 |
Why?
|
| Antibodies, Blocking | 2 | 2017 | 17 | 0.170 |
Why?
|
| Pressure | 1 | 2020 | 252 | 0.170 |
Why?
|
| Ovarian Follicle | 1 | 2019 | 21 | 0.170 |
Why?
|
| Lysosomes | 1 | 2020 | 136 | 0.170 |
Why?
|
| Metabolomics | 1 | 2019 | 28 | 0.170 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2019 | 16 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 9 | 2006 | 852 | 0.170 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 57 | 0.170 |
Why?
|
| Protein Transport | 3 | 2015 | 280 | 0.170 |
Why?
|
| Stem Cells | 1 | 2021 | 248 | 0.170 |
Why?
|
| Recurrence | 2 | 2019 | 948 | 0.170 |
Why?
|
| Gene Deletion | 2 | 2017 | 235 | 0.170 |
Why?
|
| Chemotaxis | 1 | 2019 | 38 | 0.170 |
Why?
|
| Protein Phosphatase 2 | 1 | 2019 | 67 | 0.170 |
Why?
|
| Fatty Acids | 2 | 2019 | 222 | 0.160 |
Why?
|
| Gene Ontology | 1 | 2019 | 31 | 0.160 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 245 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2022 | 337 | 0.160 |
Why?
|
| Spinal Cord | 3 | 2019 | 244 | 0.160 |
Why?
|
| Immunization | 1 | 2019 | 86 | 0.160 |
Why?
|
| STAT1 Transcription Factor | 2 | 2016 | 35 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 1083 | 0.160 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 65 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 65 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 13 | 2011 | 511 | 0.160 |
Why?
|
| Focal Adhesions | 1 | 2018 | 25 | 0.160 |
Why?
|
| Fluorouracil | 1 | 2019 | 130 | 0.160 |
Why?
|
| Estrogens | 2 | 2022 | 173 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 5 | 2020 | 532 | 0.160 |
Why?
|
| Galactosamine | 2 | 2015 | 11 | 0.160 |
Why?
|
| Cell Death | 4 | 2016 | 329 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 167 | 0.160 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 301 | 0.160 |
Why?
|
| Genistein | 1 | 2018 | 26 | 0.160 |
Why?
|
| Receptors, Interleukin-4 | 2 | 2014 | 9 | 0.160 |
Why?
|
| Gastritis | 1 | 2018 | 12 | 0.160 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2015 | 101 | 0.160 |
Why?
|
| Granulocytes | 1 | 2018 | 22 | 0.160 |
Why?
|
| Withanolides | 1 | 2018 | 1 | 0.160 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 166 | 0.160 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2018 | 19 | 0.160 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 20 | 0.160 |
Why?
|
| Magnetite Nanoparticles | 1 | 2018 | 28 | 0.160 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 97 | 0.150 |
Why?
|
| Endometrium | 1 | 2018 | 31 | 0.150 |
Why?
|
| Gold | 1 | 2018 | 76 | 0.150 |
Why?
|
| Transfection | 3 | 2016 | 782 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2016 | 37 | 0.150 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 29 | 0.150 |
Why?
|
| Smad7 Protein | 2 | 2014 | 11 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 322 | 0.150 |
Why?
|
| Cobalt | 1 | 2018 | 37 | 0.150 |
Why?
|
| Monosaccharides | 1 | 2017 | 4 | 0.150 |
Why?
|
| Clodronic Acid | 1 | 2017 | 9 | 0.150 |
Why?
|
| Penicillins | 1 | 2018 | 32 | 0.150 |
Why?
|
| Microglia | 1 | 2019 | 143 | 0.150 |
Why?
|
| Rats | 8 | 2020 | 5300 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 114 | 0.150 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 508 | 0.150 |
Why?
|
| Boron Compounds | 1 | 2017 | 21 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2015 | 331 | 0.150 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 27 | 0.150 |
Why?
|
| Thiazoles | 1 | 2018 | 95 | 0.150 |
Why?
|
| Machine Learning | 1 | 2019 | 170 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 8 | 0.150 |
Why?
|
| Ceramides | 1 | 2021 | 578 | 0.150 |
Why?
|
| Propionates | 1 | 2017 | 21 | 0.150 |
Why?
|
| Bacteroidetes | 1 | 2017 | 5 | 0.150 |
Why?
|
| Receptors, Mitogen | 1 | 2017 | 23 | 0.150 |
Why?
|
| Neoplasm Transplantation | 4 | 2012 | 160 | 0.150 |
Why?
|
| Afghan Campaign 2001- | 1 | 2017 | 78 | 0.140 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2017 | 85 | 0.140 |
Why?
|
| Models, Biological | 5 | 2017 | 981 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 22 | 0.140 |
Why?
|
| Caspase 2 | 2 | 2015 | 4 | 0.140 |
Why?
|
| Immunity | 1 | 2017 | 67 | 0.140 |
Why?
|
| Lymphoid Tissue | 1 | 1997 | 30 | 0.140 |
Why?
|
| Lipopolysaccharides | 3 | 2015 | 455 | 0.140 |
Why?
|
| Central Nervous System | 2 | 2017 | 107 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 352 | 0.140 |
Why?
|
| Quinacrine | 1 | 2016 | 10 | 0.140 |
Why?
|
| Drug Repositioning | 1 | 2016 | 8 | 0.140 |
Why?
|
| Severity of Illness Index | 5 | 2022 | 1851 | 0.140 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 41 | 0.140 |
Why?
|
| Glycerides | 1 | 2016 | 18 | 0.140 |
Why?
|
| Protein Kinase C | 2 | 2010 | 270 | 0.140 |
Why?
|
| Immunoglobulin G | 3 | 2011 | 481 | 0.140 |
Why?
|
| Radon | 1 | 1996 | 8 | 0.140 |
Why?
|
| Amidohydrolases | 1 | 2016 | 60 | 0.130 |
Why?
|
| Antimalarials | 1 | 2016 | 71 | 0.130 |
Why?
|
| Mice, Nude | 4 | 1997 | 294 | 0.130 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 29 | 0.130 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2016 | 19 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 68 | 0.130 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Leukemia, T-Cell | 2 | 2006 | 21 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2011 | 266 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2015 | 174 | 0.130 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2015 | 34 | 0.130 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Genetic Markers | 2 | 2014 | 144 | 0.130 |
Why?
|
| Immunophenotyping | 4 | 2022 | 110 | 0.130 |
Why?
|
| Body Weight | 5 | 2017 | 554 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 52 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2018 | 1040 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2010 | 238 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2017 | 156 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 102 | 0.130 |
Why?
|
| CD3 Complex | 4 | 2011 | 35 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2012 | 14 | 0.130 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 2015 | 4 | 0.130 |
Why?
|
| Young Adult | 5 | 2015 | 5717 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2015 | 26 | 0.130 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 79 | 0.130 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 8 | 0.130 |
Why?
|
| Exosomes | 1 | 2015 | 44 | 0.130 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2015 | 54 | 0.130 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 82 | 0.130 |
Why?
|
| Social Environment | 1 | 2016 | 182 | 0.120 |
Why?
|
| Biofilms | 1 | 2015 | 72 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 196 | 0.120 |
Why?
|
| STAT Transcription Factors | 2 | 2018 | 13 | 0.120 |
Why?
|
| Medical Marijuana | 1 | 2015 | 21 | 0.120 |
Why?
|
| Insecticides | 2 | 2018 | 43 | 0.120 |
Why?
|
| Endothelium | 1 | 2015 | 98 | 0.120 |
Why?
|
| Lymphocyte Count | 4 | 2014 | 53 | 0.120 |
Why?
|
| Receptors, CXCR3 | 2 | 2011 | 16 | 0.120 |
Why?
|
| Pressure Ulcer | 1 | 2015 | 40 | 0.120 |
Why?
|
| Triterpenes | 1 | 2015 | 40 | 0.120 |
Why?
|
| Encephalitis | 1 | 2014 | 43 | 0.120 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2014 | 4 | 0.120 |
Why?
|
| Intestinal Polyps | 1 | 2014 | 15 | 0.120 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 63 | 0.120 |
Why?
|
| Antigens, Differentiation | 2 | 2013 | 49 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2014 | 25 | 0.120 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2014 | 9 | 0.120 |
Why?
|
| Atrophy | 6 | 2010 | 112 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 23 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2015 | 69 | 0.120 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 765 | 0.120 |
Why?
|
| Blotting, Western | 6 | 2015 | 954 | 0.120 |
Why?
|
| Cystitis | 1 | 2013 | 18 | 0.120 |
Why?
|
| Cystitis, Interstitial | 1 | 2013 | 12 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2015 | 326 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 32 | 0.110 |
Why?
|
| DNA Damage | 2 | 2019 | 190 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2015 | 237 | 0.110 |
Why?
|
| Mothers | 1 | 2015 | 172 | 0.110 |
Why?
|
| Aldicarb | 2 | 1990 | 3 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 102 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1085 | 0.110 |
Why?
|
| Genomics | 1 | 2014 | 168 | 0.110 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 92 | 0.110 |
Why?
|
| Th1-Th2 Balance | 1 | 2012 | 10 | 0.110 |
Why?
|
| Immunotherapy | 2 | 2012 | 215 | 0.110 |
Why?
|
| Hemolysis | 3 | 2020 | 39 | 0.110 |
Why?
|
| Polyethyleneimine | 1 | 2012 | 14 | 0.110 |
Why?
|
| AIDS Dementia Complex | 1 | 2012 | 20 | 0.110 |
Why?
|
| Wound Healing | 1 | 2015 | 260 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 3 | 2015 | 87 | 0.110 |
Why?
|
| Transgenes | 1 | 2012 | 92 | 0.110 |
Why?
|
| Antibodies | 1 | 2013 | 241 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 318 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 47 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 116 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 60 | 0.100 |
Why?
|
| Administration, Intranasal | 1 | 2012 | 88 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 156 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2015 | 296 | 0.100 |
Why?
|
| Mitochondria | 3 | 2006 | 643 | 0.100 |
Why?
|
| Graft Survival | 1 | 2015 | 465 | 0.100 |
Why?
|
| Neoplasms | 2 | 2015 | 1667 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2016 | 621 | 0.100 |
Why?
|
| Rutin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Marijuana Smoking | 2 | 2011 | 108 | 0.100 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 499 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 514 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2012 | 149 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2012 | 90 | 0.100 |
Why?
|
| Jurkat Cells | 3 | 2006 | 59 | 0.100 |
Why?
|
| Random Allocation | 1 | 2013 | 442 | 0.100 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2011 | 8 | 0.100 |
Why?
|
| Microscopy | 1 | 2012 | 64 | 0.100 |
Why?
|
| L-Selectin | 1 | 2011 | 28 | 0.100 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 20 | 0.100 |
Why?
|
| Neuroglia | 1 | 2012 | 136 | 0.100 |
Why?
|
| HIV Antigens | 1 | 2011 | 9 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 2012 | 43 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 317 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2014 | 431 | 0.100 |
Why?
|
| HLA-D Antigens | 1 | 2011 | 20 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2012 | 483 | 0.100 |
Why?
|
| Mitogens | 5 | 2006 | 45 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4848 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2016 | 33 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 83 | 0.090 |
Why?
|
| Nitrosourea Compounds | 1 | 1990 | 16 | 0.090 |
Why?
|
| Nitric Oxide | 2 | 2016 | 382 | 0.090 |
Why?
|
| Butyric Acid | 2 | 2021 | 4 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 15 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 700 | 0.090 |
Why?
|
| Thymus Neoplasms | 2 | 1988 | 17 | 0.090 |
Why?
|
| Cell Count | 3 | 2006 | 248 | 0.090 |
Why?
|
| HCT116 Cells | 3 | 2020 | 63 | 0.090 |
Why?
|
| Lipids | 2 | 2022 | 298 | 0.090 |
Why?
|
| Toxoids | 1 | 2010 | 3 | 0.090 |
Why?
|
| Adenylate Kinase | 1 | 2010 | 10 | 0.090 |
Why?
|
| Breast | 1 | 2011 | 137 | 0.090 |
Why?
|
| Proteins | 2 | 2012 | 474 | 0.090 |
Why?
|
| Antigen-Presenting Cells | 4 | 2009 | 50 | 0.090 |
Why?
|
| Introns | 1 | 2010 | 68 | 0.090 |
Why?
|
| Phylogeny | 2 | 2021 | 197 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 58 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2016 | 824 | 0.090 |
Why?
|
| Cell Movement | 4 | 2017 | 630 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 1174 | 0.090 |
Why?
|
| Antigens, Surface | 3 | 1999 | 71 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2015 | 250 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2010 | 254 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 69 | 0.080 |
Why?
|
| Cytochromes c | 2 | 2006 | 75 | 0.080 |
Why?
|
| Ionomycin | 1 | 1989 | 24 | 0.080 |
Why?
|
| Sheep | 1 | 2009 | 128 | 0.080 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2004 | 9 | 0.080 |
Why?
|
| Colonoscopy | 2 | 2021 | 156 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 163 | 0.080 |
Why?
|
| Membrane Potentials | 2 | 2006 | 200 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 2009 | 72 | 0.080 |
Why?
|
| Boronic Acids | 2 | 2021 | 40 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 175 | 0.080 |
Why?
|
| DNA Primers | 4 | 2009 | 302 | 0.080 |
Why?
|
| Fluorescent Dyes | 3 | 2012 | 191 | 0.080 |
Why?
|
| Chickens | 1 | 2009 | 232 | 0.080 |
Why?
|
| Mice, Inbred MRL lpr | 3 | 2003 | 118 | 0.080 |
Why?
|
| Kupffer Cells | 2 | 2019 | 75 | 0.080 |
Why?
|
| Heterozygote | 1 | 2008 | 174 | 0.070 |
Why?
|
| Cell Communication | 1 | 2008 | 116 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 75 | 0.070 |
Why?
|
| Leukocyte Common Antigens | 3 | 2003 | 41 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Neurons | 1 | 2012 | 881 | 0.070 |
Why?
|
| bcl-Associated Death Protein | 1 | 2006 | 19 | 0.070 |
Why?
|
| NADPH Oxidase 4 | 1 | 2006 | 17 | 0.070 |
Why?
|
| Prognosis | 1 | 2011 | 2093 | 0.070 |
Why?
|
| Surface Properties | 2 | 2018 | 363 | 0.070 |
Why?
|
| Immunoglobulin M | 3 | 2003 | 172 | 0.070 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 45 | 0.070 |
Why?
|
| Syndrome | 1 | 2006 | 255 | 0.070 |
Why?
|
| Species Specificity | 1 | 2006 | 303 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2018 | 7029 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 346 | 0.070 |
Why?
|
| Toll-Like Receptors | 2 | 2016 | 56 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 134 | 0.070 |
Why?
|
| HIV-1 | 3 | 2012 | 177 | 0.070 |
Why?
|
| Leukemia, Experimental | 1 | 1985 | 14 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2018 | 85 | 0.060 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2015 | 9 | 0.060 |
Why?
|
| Spermatozoa | 1 | 2005 | 75 | 0.060 |
Why?
|
| Clone Cells | 5 | 1991 | 67 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 337 | 0.060 |
Why?
|
| Iraq | 2 | 2015 | 24 | 0.060 |
Why?
|
| Antigens, Ly | 4 | 1990 | 14 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 111 | 0.060 |
Why?
|
| Zidovudine | 2 | 1995 | 27 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 82 | 0.060 |
Why?
|
| Aging | 5 | 2010 | 911 | 0.060 |
Why?
|
| Teratogens | 1 | 2004 | 11 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2004 | 28 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2004 | 27 | 0.060 |
Why?
|
| Caspase 3 | 3 | 2015 | 233 | 0.060 |
Why?
|
| DNA, Single-Stranded | 1 | 2003 | 41 | 0.060 |
Why?
|
| Lymphatic Diseases | 1 | 2003 | 27 | 0.060 |
Why?
|
| Dengue Virus | 1 | 1983 | 3 | 0.060 |
Why?
|
| Dengue | 1 | 1983 | 5 | 0.060 |
Why?
|
| Bufo marinus | 1 | 2003 | 23 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 251 | 0.060 |
Why?
|
| Anura | 1 | 2003 | 9 | 0.060 |
Why?
|
| Limb Deformities, Congenital | 1 | 2003 | 12 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 1983 | 35 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2020 | 175 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2004 | 308 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2003 | 42 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 204 | 0.050 |
Why?
|
| Crohn Disease | 2 | 2015 | 38 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 357 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2018 | 617 | 0.050 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2022 | 19 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2022 | 49 | 0.050 |
Why?
|
| Neutrophils | 2 | 2015 | 204 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2001 | 94 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2021 | 295 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 246 | 0.050 |
Why?
|
| Chryseobacterium | 1 | 2022 | 2 | 0.050 |
Why?
|
| Adiponectin | 1 | 2022 | 52 | 0.050 |
Why?
|
| Mice, Inbred Strains | 5 | 1990 | 181 | 0.050 |
Why?
|
| RNA | 1 | 2003 | 171 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 324 | 0.050 |
Why?
|
| HIV Infections | 1 | 2010 | 791 | 0.050 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 74 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2022 | 52 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2022 | 17 | 0.050 |
Why?
|
| Angiotensin II | 2 | 2015 | 220 | 0.050 |
Why?
|
| Celiac Disease | 1 | 2022 | 17 | 0.050 |
Why?
|
| Symbiosis | 1 | 2022 | 19 | 0.050 |
Why?
|
| Insulin | 2 | 2016 | 619 | 0.050 |
Why?
|
| Nasopharynx | 1 | 2021 | 7 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 525 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2022 | 234 | 0.050 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2021 | 15 | 0.050 |
Why?
|
| Alanine Transaminase | 2 | 2015 | 137 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2012 | 22 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2021 | 53 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 35 | 0.050 |
Why?
|
| Polyesters | 1 | 2021 | 55 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2010 | 411 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2006 | 138 | 0.050 |
Why?
|
| Risk Factors | 1 | 2011 | 5731 | 0.050 |
Why?
|
| Mauritius | 1 | 2021 | 3 | 0.050 |
Why?
|
| Toxicity Tests, Subchronic | 1 | 2021 | 3 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 73 | 0.050 |
Why?
|
| Glucuronides | 1 | 2021 | 5 | 0.050 |
Why?
|
| California | 1 | 2021 | 99 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 111 | 0.050 |
Why?
|
| Plant Leaves | 1 | 2021 | 49 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 215 | 0.050 |
Why?
|
| Chromium Radioisotopes | 2 | 2011 | 11 | 0.050 |
Why?
|
| Geologic Sediments | 1 | 2021 | 75 | 0.050 |
Why?
|
| Helicobacter | 1 | 2020 | 5 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 307 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2021 | 107 | 0.050 |
Why?
|
| Myoblasts | 1 | 2020 | 22 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 139 | 0.050 |
Why?
|
| Mucous Membrane | 2 | 2011 | 66 | 0.050 |
Why?
|
| Vacuoles | 1 | 2020 | 10 | 0.050 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2020 | 3 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2015 | 396 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 1998 | 100 | 0.050 |
Why?
|
| Streptozocin | 2 | 1990 | 34 | 0.050 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 32 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2020 | 89 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 240 | 0.040 |
Why?
|
| Genes, ras | 1 | 2020 | 46 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 150 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 34 | 0.040 |
Why?
|
| Estradiol | 1 | 2001 | 176 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2019 | 4 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 381 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 85 | 0.040 |
Why?
|
| Lysine | 1 | 2020 | 96 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 455 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 2083 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 30 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2019 | 20 | 0.040 |
Why?
|
| Survival Rate | 1 | 2002 | 1056 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 2019 | 11 | 0.040 |
Why?
|
| Mesoderm | 1 | 2020 | 231 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 57 | 0.040 |
Why?
|
| Cholic Acid | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2020 | 133 | 0.040 |
Why?
|
| Cations | 1 | 2018 | 51 | 0.040 |
Why?
|
| Drug Resistance | 1 | 1999 | 223 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2455 | 0.040 |
Why?
|
| Cyclin E | 1 | 2018 | 19 | 0.040 |
Why?
|
| Stress Fibers | 1 | 2018 | 10 | 0.040 |
Why?
|
| Nanostructures | 1 | 2020 | 112 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 2 | 1996 | 34 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 2011 | 76 | 0.040 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2018 | 2 | 0.040 |
Why?
|
| Permethrin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 17 | 0.040 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2018 | 14 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 284 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 2 | 1998 | 8 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2018 | 11 | 0.040 |
Why?
|
| Perforin | 2 | 1998 | 12 | 0.040 |
Why?
|
| Nigericin | 1 | 2018 | 3 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2018 | 7 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 420 | 0.040 |
Why?
|
| HT29 Cells | 2 | 2008 | 42 | 0.040 |
Why?
|
| Fibronectins | 1 | 2018 | 130 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 362 | 0.040 |
Why?
|
| Methacrylates | 1 | 2018 | 31 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2008 | 282 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2018 | 45 | 0.040 |
Why?
|
| Mesangial Cells | 1 | 2018 | 37 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2018 | 64 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 3187 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2017 | 27 | 0.040 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2017 | 1 | 0.040 |
Why?
|
| CD4 Antigens | 3 | 1992 | 42 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Static Electricity | 1 | 2018 | 91 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Claudin-2 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 135 | 0.040 |
Why?
|
| Lectins | 1 | 2017 | 81 | 0.040 |
Why?
|
| Bone Marrow | 2 | 2010 | 168 | 0.040 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1997 | 5 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2017 | 27 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 98 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2016 | 3 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1997 | 48 | 0.040 |
Why?
|
| Liposomes | 1 | 2017 | 107 | 0.040 |
Why?
|
| Transcription Factor CHOP | 1 | 2016 | 28 | 0.040 |
Why?
|
| Oxazolone | 1 | 2016 | 2 | 0.040 |
Why?
|
| Raphe Nuclei | 1 | 2016 | 10 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2019 | 307 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2016 | 22 | 0.030 |
Why?
|
| Anhedonia | 1 | 2016 | 15 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1996 | 5 | 0.030 |
Why?
|
| Dust | 1 | 1996 | 9 | 0.030 |
Why?
|
| Alpha Particles | 1 | 1996 | 9 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 35 | 0.030 |
Why?
|
| Aerosols | 1 | 1996 | 42 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2016 | 24 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 150 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2016 | 55 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 99 | 0.030 |
Why?
|
| Body Composition | 1 | 2016 | 119 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2016 | 25 | 0.030 |
Why?
|
| Heart | 1 | 2021 | 850 | 0.030 |
Why?
|
| Uranium | 1 | 1996 | 26 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 100 | 0.030 |
Why?
|
| Amiloride | 1 | 2015 | 22 | 0.030 |
Why?
|
| Benzylidene Compounds | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cycloaddition Reaction | 1 | 2015 | 6 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2016 | 203 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 32 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 658 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2015 | 52 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1996 | 187 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2017 | 215 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cholesterol | 1 | 2016 | 331 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1992 | 86 | 0.030 |
Why?
|
| Adolescent | 3 | 2015 | 8912 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2015 | 9 | 0.030 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 567 | 0.030 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2014 | 3 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 89 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2014 | 18 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 2015 | 41 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2015 | 42 | 0.030 |
Why?
|
| Trihalomethanes | 1 | 2014 | 37 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2015 | 213 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 196 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 15 | 0.030 |
Why?
|
| beta-Lactamases | 1 | 2014 | 33 | 0.030 |
Why?
|
| Chemokine CXCL11 | 1 | 2013 | 3 | 0.030 |
Why?
|
| beta-Lactams | 1 | 2014 | 29 | 0.030 |
Why?
|
| Chemokine CXCL9 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 332 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 144 | 0.030 |
Why?
|
| Granzymes | 1 | 1993 | 19 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2014 | 26 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 304 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 137 | 0.030 |
Why?
|
| Child | 2 | 2015 | 6405 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2014 | 305 | 0.030 |
Why?
|
| Apyrase | 1 | 2013 | 10 | 0.030 |
Why?
|
| Proteomics | 1 | 2015 | 246 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 631 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 95 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 447 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 145 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2012 | 12 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 80 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2012 | 40 | 0.030 |
Why?
|
| Doxycycline | 1 | 2013 | 49 | 0.030 |
Why?
|
| Chemical Fractionation | 1 | 2012 | 18 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 282 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.030 |
Why?
|
| Resins, Plant | 1 | 2011 | 4 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 59 | 0.030 |
Why?
|
| Plants | 1 | 2012 | 26 | 0.030 |
Why?
|
| Immunoblastic Lymphadenopathy | 1 | 1991 | 1 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1991 | 5 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 72 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2011 | 13 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 27 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2011 | 23 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2011 | 20 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2011 | 16 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2011 | 28 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2011 | 13 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 236 | 0.020 |
Why?
|
| CpG Islands | 1 | 2011 | 51 | 0.020 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 33 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2011 | 33 | 0.020 |
Why?
|
| Biological Assay | 1 | 2012 | 88 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2011 | 59 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2011 | 108 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2011 | 79 | 0.020 |
Why?
|
| Aorta | 1 | 2012 | 316 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 138 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 29 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2010 | 3 | 0.020 |
Why?
|
| PAX2 Transcription Factor | 1 | 2010 | 11 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 238 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 1990 | 25 | 0.020 |
Why?
|
| Chloroquine | 1 | 1990 | 21 | 0.020 |
Why?
|
| Virus Latency | 1 | 2010 | 10 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 186 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 48 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2010 | 46 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1603 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 237 | 0.020 |
Why?
|
| Mesentery | 1 | 2009 | 17 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 1989 | 25 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 271 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 168 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 63 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2009 | 98 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2008 | 6 | 0.020 |
Why?
|
| Comet Assay | 1 | 2008 | 11 | 0.020 |
Why?
|
| Ginkgo biloba | 1 | 2008 | 4 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 2891 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 196 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 492 | 0.020 |
Why?
|
| Leukocytes | 1 | 2008 | 99 | 0.020 |
Why?
|
| DNA Replication | 1 | 1989 | 167 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 245 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 848 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2007 | 25 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 34 | 0.020 |
Why?
|
| Spermine | 1 | 2007 | 49 | 0.020 |
Why?
|
| E2F1 Transcription Factor | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 99 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2007 | 54 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 33 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2006 | 20 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2006 | 22 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 17 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2006 | 72 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 191 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 282 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 32 | 0.020 |
Why?
|
| Succinimides | 1 | 2005 | 11 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2006 | 122 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2005 | 31 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1985 | 24 | 0.020 |
Why?
|
| Epididymis | 1 | 2005 | 10 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 55 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2005 | 147 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2005 | 14 | 0.020 |
Why?
|
| Cytosol | 1 | 2005 | 123 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2005 | 113 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2004 | 22 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 389 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2005 | 97 | 0.010 |
Why?
|
| Sexual Abstinence | 1 | 2004 | 1 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 40 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2005 | 94 | 0.010 |
Why?
|
| Kinetics | 3 | 1991 | 1047 | 0.010 |
Why?
|
| Dinitrofluorobenzene | 1 | 1983 | 2 | 0.010 |
Why?
|
| Bermuda | 1 | 2003 | 1 | 0.010 |
Why?
|
| Trematoda | 1 | 2003 | 3 | 0.010 |
Why?
|
| Povidone | 1 | 1983 | 12 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 597 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 155 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1999 | 48 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 2 | 1989 | 5 | 0.010 |
Why?
|
| Autoantigens | 2 | 1989 | 91 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1996 | 10 | 0.010 |
Why?
|
| Homozygote | 1 | 1996 | 119 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 376 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1997 | 493 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1991 | 12 | 0.010 |
Why?
|
| Hybridomas | 1 | 1990 | 25 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1990 | 29 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1990 | 107 | 0.010 |
Why?
|
| Thy-1 Antigens | 1 | 1988 | 4 | 0.010 |
Why?
|
| Culture Media | 1 | 1988 | 155 | 0.000 |
Why?
|
| Lymphocyte Depletion | 1 | 1988 | 34 | 0.000 |
Why?
|
| Isoantibodies | 1 | 1988 | 35 | 0.000 |
Why?
|
| Dinoprostone | 1 | 1989 | 110 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1990 | 434 | 0.000 |
Why?
|
| Age Factors | 1 | 1991 | 1864 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1985 | 7 | 0.000 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1988 | 756 | 0.000 |
Why?
|